CSC
HALO icon

Caldwell Sutter Capital’s Halozyme HALO Stock Holding History

Caldwell Sutter Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7K Sell
200
-100
-33% -$6.82K 0.01% 561
2026
Q1 		$19.4K Hold
300
– – 0.01% 489
2025
Q4 		$20.2K Hold
300
– – 0.01% 471
2025
Q3 		$22K Buy
+300
New +$19.9K 0.01% 462

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Caldwell Sutter Capital's HALO Position: Q2 2026 in Review

Caldwell Sutter Capital reduced its Halozyme (HALO) stake by 33% in Q2 2026, selling an estimated $6.82K and leaving 200 shares worth $15.7K. The position accounts for 0.01% of the portfolio, ranked #561.

Caldwell Sutter Capital first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. The position peaked at $22K in Q3 2025. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Caldwell Sutter Capital held 200 shares of Halozyme worth $15.7K as of Q2 2026.
  • Caldwell Sutter Capital sold 100 Halozyme shares in Q2 2026, an estimated $6.82K.
  • Halozyme made up 0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #561 holding.
  • Caldwell Sutter Capital first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
  • Caldwell Sutter Capital's Halozyme position peaked at $22K in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.